Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative effectiveness research: the view from the NHLBI.

Literature DB >> 19298925

Comparative effectiveness research: the view from the NHLBI.

Michael S Lauer¹.

Abstract

Entities: Chemical Disease Species

Mesh：

Year: 2009 PMID： 19298925 PMCID： PMC2692180 DOI： 10.1016/j.jacc.2008.11.047

Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094

× No keyword cloud information.

14 in total

1. What cannot be said on television about health care.

Authors: Ezekiel J Emanuel
Journal: JAMA Date: 2007-05-16 Impact factor: 56.272

2. Information on cost-effectiveness: an essential product of a national comparative effectiveness program.

Authors:
Journal: Ann Intern Med Date: 2008-05-15 Impact factor: 25.391

3. Defining optimal research study design for cardiovascular imaging using computed tomography angiography as a model.

Authors: Bimal R Shah; Manesh R Patel; Eric D Peterson; Pamela S Douglas
Journal: Am J Cardiol Date: 2008-07-17 Impact factor: 2.778

4. Shattuck lecture--outcomes management. A technology of patient experience.

Authors: P M Ellwood
Journal: N Engl J Med Date: 1988-06-09 Impact factor: 91.245

5. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors: Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal: N Engl J Med Date: 2005-01-20 Impact factor: 91.245

6. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction.

Authors: Therese A Stukel; F Lee Lucas; David E Wennberg
Journal: JAMA Date: 2005-03-16 Impact factor: 56.272

7. Coronary intervention for persistent occlusion after myocardial infarction.

Authors: Judith S Hochman; Gervasio A Lamas; Christopher E Buller; Vladimir Dzavik; Harmony R Reynolds; Staci J Abramsky; Sandra Forman; Witold Ruzyllo; Aldo P Maggioni; Harvey White; Zygmunt Sadowski; Antonio C Carvalho; Jamie M Rankin; Jean P Renkin; P Gabriel Steg; Alice M Mascette; George Sopko; Matthias E Pfisterer; Jonathan Leor; Viliam Fridrich; Daniel B Mark; Genell L Knatterud
Journal: N Engl J Med Date: 2006-11-14 Impact factor: 91.245

8. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.

Authors: Miguel A Hernán; Alvaro Alonso; Roger Logan; Francine Grodstein; Karin B Michels; Walter C Willett; Joann E Manson; James M Robins
Journal: Epidemiology Date: 2008-11 Impact factor: 4.822

9. Effects of intensive glucose lowering in type 2 diabetes.

Authors: Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal: N Engl J Med Date: 2008-06-06 Impact factor: 91.245

10. Is technological change in medicine always worth it? The case of acute myocardial infarction.

Authors: Jonathan S Skinner; Douglas O Staiger; Elliott S Fisher
Journal: Health Aff (Millwood) Date: 2006-02-07 Impact factor: 9.048

9 in total

1. Full report from the first annual Heart Rhythm Society Research Forum: a vision for our research future, "dream, discover, develop, deliver".

Authors: Christine M Albert; Peng-Sheng Chen; Mark E Anderson; Michael E Cain; Glenn I Fishman; Sanjiv M Narayan; Jeffrey E Olgin; Peter M Spooner; William G Stevenson; David R Van Wagoner; Douglas L Packer
Journal: Heart Rhythm Date: 2011-11-07 Impact factor: 6.343

2. What have we learned about trial design from NIMH-funded pragmatic trials?

Authors: John March; Helena C Kraemer; Madhukar Trivedi; John Csernansky; John Davis; Terence A Ketter; Ira D Glick
Journal: Neuropsychopharmacology Date: 2010-08-25 Impact factor: 7.853

3. Comparative effectiveness regulations and pharmaceutical innovation.

Authors: John A Vernon; Joseph H Golec; J Stedman Stevens
Journal: Pharmacoeconomics Date: 2010 Impact factor: 4.981

4. Evaluating the effectiveness of a rapidly adopted cardiovascular technology with administrative data: the case of drug-eluting stents for acute coronary syndromes.

Authors: Jerome J Federspiel; Sally C Stearns; Brett C Sheridan; Jack J Kuritzky; Laura P D'Arcy; Daniel J Crespin; Timothy S Carey; Joseph S Rossi
Journal: Am Heart J Date: 2012-08 Impact factor: 4.749

5. Comparative effectiveness research.

Authors: J A Hirsch; P W Schaefer; J M Romero; J D Rabinov; P C Sanelli; L Manchikanti
Journal: AJNR Am J Neuroradiol Date: 2014-05-29 Impact factor: 3.825

6. Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.

Authors: Linda B Piller; Lara M Simpson; Sarah Baraniuk; Gabriel B Habib; Mahboob Rahman; Jan N Basile; Richard A Dart; Allan J Ellsworth; Herbert Fendley; Jeffrey L Probstfield; Paul K Whelton; Barry R Davis
Journal: J Gen Intern Med Date: 2014-11 Impact factor: 5.128